Gyre Therapeutics (GYRE) Treasury Shares (2011 - 2019)

Gyre Therapeutics (GYRE) has 9 years of Treasury Shares data on file, last reported at $1.6 million in Q4 2019.

• Treasury Shares for Q4 2019 came in at $1.6 million, changed N/A year-over-year; the trailing twelve-month figure through Dec 2019 was $1.6 million (changed N/A YoY), and the FY2019 annual result was $1.6 million, changed N/A from the prior year.
• Treasury Shares held at $1.6 million in Q4 2019 per GYRE's latest filing, from $1.6 million in the prior quarter.
• Over five years, Treasury Shares peaked at $1.6 million in Q2 2019 and troughed at $44704.0 in Q1 2017.
• A 5-year average of $975708.1 and a median of $1.0 million in 2018 frame the typical range for Treasury Shares.
• The sharpest annual moves came in 2015 and 2018: Treasury Shares plunged 79.89% in 2015, then soared 2195.98% in 2018.
• A 5-year view of Treasury Shares shows it stood at $103129.0 in 2015, then soared by 36.71% to $140990.0 in 2016, then soared by 482.84% to $821741.0 in 2017, then surged by 60.53% to $1.3 million in 2018, then advanced by 19.59% to $1.6 million in 2019.
• Business Quant data shows GYRE's Treasury Shares at $1.6 million in Q4 2019, $1.6 million in Q3 2019, and $1.6 million in Q2 2019.